Ckd Anemia

Iron deficiency may be linked to non-dialysis-dependent chronic kidney disease and mortality in patients without anemia, according to results of a nationwide cohort study.

Patients with chronic kidney disease and heart failure who took the sodium glucose co-transporter 2 inhibitor empagliflozin saw a stabilization of ejection fraction and a slowing in eGFR decline, according to trial results presented here.

The oral anemia drug daprodustat showed noninferiority to erythropoiesis-stimulating agents for achieving targeted hemoglobin levels and cardiovascular risk in patients with kidney disease on dialysis and not on dialysis, according to phase 3 data presented at ASN Kidney Week.